Healthcare and Life Science
DLOC partners with 42 Technology to develop ‘human-on-chip’ system
DLOC Biosystems (DLOC), a spin-out from the American University of Beirut, has appointed 42 Technology (42T) as a strategic product development partner to help bring its advanced 3D human-on-chip technology and fully-automated operating system to market. ...
Elucidare receives award to develop spatial audio applications for mental health therapies
Elucidare, the commercialization and investment due diligence consultancy, announces the receipt of an award from Innovate UK for the development of spatial audio as a mental health therapy. ...
NK:IO raises £1.2M, bringing total Seed funding to £5.1M, to advance pioneering NK cell therapy
NK:IO, a leader in natural killer (NK) cell biology applied to the development of exceptionally potent, off-the-shelf cell therapies targeting solid tumours, has raised £1.2M. This brings total equity financing to £3.2M and will enable the company to reach key milestones in progressing ...
D-CYPHR goes live across the UK
Largest ever DNA and health research programme for children and young people launches to tackle toughest health challenges – through the power of spit. ...
AudioTelligence breaks new ground in Assistive Tech with Earbud Assistive Listening Case
AudioTelligence announces its innovative new product concept, which for the first time integrates assistive listening technology into an earbud charging case. This world-first combination of hearing technology with earbud charging facilities provides manufacturers with a comprehen...
Abzena appoints Thomas Castellano as Chief Financial Officer
Abzena, the leading end-to-end integrated CDMO for complex biologic molecules and Antibody Drug Conjugates (ADCs) has announced the appointment of Thomas Castellano, as Chief Financial Officer. ...
Qkine announces collaboration with Sartorius
Qkine, a manufacturer of animal-free, highly bioactive, and innovative proteins, announces its collaboration with Sartorius, a global life science group, to supply growth factors and cytokines for stem cell and organoid research, as part of a comprehensive workflow solution. ...
Camena Bioscience close $10 Series A financing as demand for DNA synthesis technology increases
Camena Bioscience, a synthetic biology company providing genes to the pharmaceutical and biotechnology industries, today announced it has closed a $10m Series A financing round, led by Mercia. The new funding will be used to scale operations and continue development of its pioneering DN...
Qureight collaborates with AstraZeneca on lung disease research
Cambridge-based data analytics company Qureight has entered into a multi-year collaboration with biopharmaceutical company AstraZeneca. ...
Cambridge Enterprise celebrates a year of innovation and economic growth
Cambridge Enterprise, the research commercialisation arm of the University of Cambridge, marked its 15th anniversary with a remarkable series of achievements. ...